| Title : Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design - Bonaca_2022_Eur.Heart.J.Cardiovasc.Pharmacother_8_243 |
| Author(s) : Bonaca MP , George RT , Morrow DA , Bergmark BA , Park JG , Abuhatzira L , Vavere AL , Karathanasis SK , Jin C , She D , Hirshberg B , Hsia J , Sabatine MS |
| Ref : Eur Heart J Cardiovasc Pharmacother , 8 :243 , 2022 |
| Abstract : Bonaca_2022_Eur.Heart.J.Cardiovasc.Pharmacother_8_243 |
| ESTHER : Bonaca_2022_Eur.Heart.J.Cardiovasc.Pharmacother_8_243 |
| PubMedSearch : Bonaca_2022_Eur.Heart.J.Cardiovasc.Pharmacother_8_243 |
| PubMedID: 33493256 |
Bonaca MP, George RT, Morrow DA, Bergmark BA, Park JG, Abuhatzira L, Vavere AL, Karathanasis SK, Jin C, She D, Hirshberg B, Hsia J, Sabatine MS (2022)
Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design
Eur Heart J Cardiovasc Pharmacother
8 :243
Bonaca MP, George RT, Morrow DA, Bergmark BA, Park JG, Abuhatzira L, Vavere AL, Karathanasis SK, Jin C, She D, Hirshberg B, Hsia J, Sabatine MS (2022)
Eur Heart J Cardiovasc Pharmacother
8 :243